Skip to main content

CORRECTION article

Front. Oncol., 07 February 2023
Sec. Breast Cancer
Volume 13 - 2023 | https://doi.org/10.3389/fonc.2023.1149399

Corrigendum: Severe toxic rhabdomyolysis under combined palbociclib and simvastatin treatment: A case report

This article is a correction to:

  1. Severe toxic rhabdomyolysis under combined palbociclib and simvastatin treatment: A case report

    1. Read original article
Franois PoumeaudFrançois Poumeaud1Anna FontanierAnna Fontanier2Jrmie DionJérémie Dion3Quentin MathevetQuentin Mathevet2Olivier CointaultOlivier Cointault4Emmanuelle Uro-CosteEmmanuelle Uro-Coste5Cline MartyCéline Marty2Florence DalencFlorence Dalenc1Pierre GirardiePierre Girardie6Anaïs Rataboul*Anaïs Rataboul1*
  • 1Department of Medical Oncology, Institut Claudius Regaud - Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France
  • 2Department of Clinical Pharmacy, Institut Claudius Regaud - Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, France
  • 3Department of Internal Medicine and Clinical Immunology, Centre Hospitalier Universitaire Toulouse, Toulouse, France
  • 4Department of Nephrology, Centre Hospitalier Universitaire Toulouse, Toulouse, France
  • 5Department of Anatomo-pathology, Institut Universitaire du Cancer de Toulouse –Oncopole, Toulouse, France
  • 6Department of Neurology, Centre Hospitalier Universitai Toulouse –Purpan, Toulouse, France

A corrigendum on
Severe toxic rhabdomyolysis under combined palbociclib and simvastatin treatment: A case report

By Poumeaud F, Fontanier A, Dion J, Mathevet Q, Cointault O, Uro-Coste E, Marty C, Dalenc F, Girardie P and Rataboul A (2022). 12:1026434. doi: 10.3389/fonc.2022.1026434

Error in Author List

In the published article, there was an error in the author list, and author’s first and last names were erroneously inverted. The corrected author list appears below.

François Poumeaud, Anna Fontanier, Jérémie Dion, Quentin Mathevet, Olivier Cointault, Emmanuelle Uro-Coste, Céline Marty, Florence Dalenc, Pierre Girardie6 and Anaïs Rataboul1*

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: rhabdomyolysis, palbociclib, simvastatin, interaction, myositis, plasmatic exchange

Citation: Poumeaud F, Fontanier A, Dion J, Mathevet Q, Cointault O, Uro-Coste E, Marty C, Dalenc F, Girardie P and Rataboul A (2023) Corrigendum: Severe toxic rhabdomyolysis under combined palbociclib and simvastatin treatment: A case report. Front. Oncol. 13:1149399. doi: 10.3389/fonc.2023.1149399

Received: 21 January 2023; Accepted: 30 January 2023;
Published: 07 February 2023.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2023 Poumeaud, Fontanier, Dion, Mathevet, Cointault, Uro-Coste, Marty, Dalenc, Girardie and Rataboul. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Anaïs Rataboul, rataboul.anais@iuct-oncopole.fr

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.